Navigation Links
Rising Rates Of C.Difficile Infection Among Non-Hospitalized Patients

Report of the rising rates of infection with C.difficile among the general public has led to concerns regarding the mutation of the microorganism into a more virulent form.// It was previously thought that the infection could only manifest in individuals with resistance to antibiotics.

The high incidence of the infection even among non-hospitalized patients has created much panic among the scientific community. "That is really a remarkably high increase in cases. "I think this needs verification in another database, to tell you the truth. And it may be that it's true. And it may be that there's something going on, " said Dr. Dale Gerding, a leading U.S. expert in the field.

The researchers examined a large database for identification of C. difficile infected cases in Britain. Surprisingly, the individuals identified did not have a positive history of hospital admission the previous year. The results of the present study have been presented in the Journal of the American Medical Association.

Infection with the microorganism is most commonly hospital acquired with a majority of the cases occurring within health-care facilities. High rates of antibiotic usage and the difficulty to eradicate the sporocytic form of C. difficile are some of the factors believed to account for the high rates of infection in hospitals.

The consumption of antibiotics destroys the natural bacterial flora present in the intestine, and enhances the susceptibility to the infection. C.difficile now happily grows and thrives in an otherwise hostile environment leading to symptoms such as severe diarrhea, abdominal pain, and fever.

An alarming rate of the infection incidence in Britain from 1 to 22 cases per 100, 000 has been found during the 10-year period (1994- 2004). Out of this, only 37% of the infected individuals had taken antibiotics prior to the infection episode.

In addition it was found that those taking Nexium (pro ton pump inhibitors, powerful antacid drugs) were three times more likely to contract the infection. Accidentally, it was found that patients on non-steroidal anti-inflammatory drugs (NSAIDs) also had an elevated risk.

The new potent strain of the bacterium is known for production of massive levels of toxic substances compared to the traditional ones. It has been held responsible for deadly outbreaks that have plagued hospitals in parts of Quebec over the few years. Appropriate techniques have to be taken to identify genetic changes within such potent forms even before permutation can occur.


'"/>




Related medicine news :

1. With More Appearance Conscious Consumers The Need For Slimming Products Is Rapidly Rising
2. Rising Rates of Whooping Cough in Idaho
3. Breast Cancer In India Rising Rapidly
4. Rising Medicare costs
5. Rising in career top charts is Medical transcription
6. Rising Number of Preterm Births Cause Concern
7. Rising Rates of Obesity and Diabetes Puts Pressure on the Australians
8. UN Sounds Alarm Over Rising Cocaine Consumption In Europe
9. Government Failed to Prevent Rising Teen Pregnancies
10. Drug Prices Rising Faster Than Inflation
11. Rising numbers indicate looming cocaine epidemic
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/27/2016)... ... 27, 2016 , ... An educational campaign aimed at everyone ... courtesy of awareness-driven celebrities and thought leaders. It also provides insight to the ... leaders such as Bioness. , As patients feel increasingly concerned about the ...
(Date:5/27/2016)... ... May 27, 2016 , ... Beleza Medspa has initiated ... regulations. This is the first time that Coolsculpting is being used for for ... six months to ensure they meet the prescribed body-fat standard, measured by the circumference-based ...
(Date:5/27/2016)... ... May 27, 2016 , ... Aimed at nurses and ... stories, which come courtesy of leaders in the nursing and health care industry. It ... advocates and associations—namely Abilene Christian University. , As the nursing industry is coming ...
(Date:5/27/2016)... (PRWEB) , ... May 27, 2016 , ... ... trusted name in the pharmaceutical, medical and food industries. Aside from its GMP ... certification (SIC), providing proof of successfully certified products, services and staff. , Validation ...
(Date:5/26/2016)... ... May 26, 2016 , ... There are many ways ... and Sausage Council (NHDSC) suggests that Americans prefer their dogs straight off the grill. ... say grilling is their favorite way to cook a hot dog, far outpacing other ...
Breaking Medicine News(10 mins):
(Date:5/27/2016)... Kitov Pharmaceuticals ... late-stage drug development, today announced the completion of ... batches required for registration of KIT-302 with the ... Kitov,s announcement in December 2015, that ... primary efficacy endpoint. "We are fortunate ...
(Date:5/26/2016)... May 26, 2016 A key ... is the emergence of new treatments. Cardax, a development ... osteoarthritis treatment. The therapy is expected to fulfil large ... UK is conducting studies to develop new treatments for ... the genes involved in osteoarthritis are being investigated, and ...
(Date:5/25/2016)... FDA 510(k) clearance covers Confocal Miniprobes ... and surgical applications Mauna Kea Technologies ... multidisciplinary confocal laser endomicroscopy (CLE) platform, today announced ... the 12 th 510(k) clearance from United ... FDA clearance covers Confocal Miniprobes indicated for use ...
Breaking Medicine Technology: